相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of bumetanide, a selective NKCC1 inhibitor, on hallucinations of schizophrenic patients; a double-blind randomized clinical trial
Reza Rahmanzadeh et al.
SCHIZOPHRENIA RESEARCH (2017)
Drug discovery using clinical outcome-based Connectivity Mapping: application to ovarian cancer
Rama Raghavan et al.
BMC GENOMICS (2016)
Gene-set analysis based on the pharmacological profiles of drugs to identify repurposing opportunities in schizophrenia
Simone de Jong et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Meta-analysis of genome-wide association studies of anxiety disorders (vol 21, pg 1391, 2016)
T. Otowa et al.
MOLECULAR PSYCHIATRY (2016)
Integrative approaches for large-scale transcriptome-wide association studies
Alexander Gusev et al.
NATURE GENETICS (2016)
Translating genome-wide association findings into new therapeutics for psychiatry
Gerome Breen et al.
NATURE NEUROSCIENCE (2016)
The statistical properties of gene-set analysis
Christiaan A. de Leeuw et al.
NATURE REVIEWS GENETICS (2016)
Bipolar Disorder: Role of Inflammation and the Development of Disease Biomarkers
Ather Muneer
PSYCHIATRY INVESTIGATION (2016)
Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach
Douglas M. Ruderfer et al.
LANCET PSYCHIATRY (2016)
Targeting the schizophrenia genome: a fast track strategy from GWAS to clinic
T. Lencz et al.
MOLECULAR PSYCHIATRY (2015)
Sparse whole-genome sequencing identifies two loci for major depressive disorder
Na Cai et al.
NATURE (2015)
The support of human genetic evidence for approved drug indications
Matthew R. Nelson et al.
NATURE GENETICS (2015)
A gene-based association method for mapping traits using reference transcriptome data
Eric R. Gamazon et al.
NATURE GENETICS (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
MAGMA: Generalized Gene-Set Analysis of GWAS Data
Christiaan A. de Leeuw et al.
PLOS COMPUTATIONAL BIOLOGY (2015)
Multi-target pharmacology: possibilities and limitations of the skeleton key approach from a medicinal chemist perspective
Alan Talevi
FRONTIERS IN PHARMACOLOGY (2015)
Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses
David C. Henderson et al.
LANCET PSYCHIATRY (2015)
GWAS and drug targets
Chen Cao et al.
BMC GENOMICS (2014)
Statin use and risk of depression: a Swedish national cohort study
Cassie Redlich et al.
BMC PSYCHIATRY (2014)
Characterizing the genetic basis of transcriptome diversity through RNA-sequencing of 922 individuals
Alexis Battle et al.
GENOME RESEARCH (2014)
Statins use and risk of depression: A systematic review and meta-analysis
Ajay K. Parsaik et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies
Mark E. Glickman et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2014)
Biological insights from 108 schizophrenia-associated genetic loci
Stephan Ripke et al.
NATURE (2014)
STUDY DESIGNS Statistical power and significance testing in large-scale genetic studies
Pak C. Sham et al.
NATURE REVIEWS GENETICS (2014)
Systematic evaluation of connectivity map for disease indications
Jie Cheng et al.
GENOME MEDICINE (2014)
The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders
Isabella Pacchiarotti et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Double-Blind, Placebo-Controlled Trial of Risperidone Plus Amantadine in Children With Autism: A 10-Week Randomized Study
Mohammad-Reza Mohammadi et al.
CLINICAL NEUROPHARMACOLOGY (2013)
A randomized add-on trial of high-dose D-cycloserine for treatment-resistant depression
Uriel Heresco-Levy et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Development and evaluation of an ensemble resource linking medications to their indications
Wei-Qi Wei et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2013)
A mega-analysis of genome-wide association studies for major depressive disorder
Patrick F. Sullivan et al.
MOLECULAR PSYCHIATRY (2013)
Autism-related deficits via dysregulated eIF4E-dependent translational control
Christos G. Gkogkas et al.
NATURE (2013)
The Genotype-Tissue Expression (GTEx) project
John Lonsdale et al.
NATURE GENETICS (2013)
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2013)
Effects of ifenprodil on the antidepressant-like activity of NMDA ligands in the forced swim test in mice
Ewa Poleszak et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Adjunctive Atypical Antipsychotic Treatment for Major Depressive Disorder: A Meta-Analysis of Depression, Quality of Life, and Safety Outcomes
Glen I. Spielmans et al.
PLOS MEDICINE (2013)
Use of genome-wide association studies for drug repositioning
Philippe Sanseau et al.
NATURE BIOTECHNOLOGY (2012)
Loop Diuretics Have Anxiolytic Effects in Rat Models of Conditioned Anxiety
Andrew D. Krystal et al.
PLOS ONE (2012)
Metyrapone in treatment-resistant depression
Paul David Sigalas et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2012)
Anxiety Disorders and Antipsychotic Drugs: A Pressing Need for More Research
Alan Breier
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Exploiting drug-disease relationships for computational drug repositioning
Joel T. Dudley et al.
BRIEFINGS IN BIOINFORMATICS (2011)
Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4
Pamela Sklar et al.
NATURE GENETICS (2011)
Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease
Joel T. Dudley et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data
Marina Sirota et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Efficacy of antidepressants in treating the negative symptoms of chronic schizophrenia: meta-analysis
Surendra P. Singh et al.
BRITISH JOURNAL OF PSYCHIATRY (2010)
Meta-Analysis of Genome-Wide Association Studies of Attention-Deficit/Hyperactivity Disorder
Benjamin M. Neale et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2010)
Double-blind placebo-controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism
Shahin Akhondzadeh et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
SIMULTANEOUS INFERENCE: WHEN SHOULD HYPOTHESIS TESTING PROBLEMS BE COMBINED?
Bradley Efron
ANNALS OF APPLIED STATISTICS (2008)
Antidepressant efficacy of the antimuscarinic drug scopolamine - A randomized, placebo-controlled clinical trial
Maura L. Furey et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: a double-blind placebo-controlled study
MC Jockers-Scherubl et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2005)
Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap
A Kentsis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Ketoconazole in bipolar patients with depressive symptoms: a case series and literature review
ES Brown et al.
BIPOLAR DISORDERS (2001)
Efficacy of kava extract for treating anxiety: Systematic review and meta-analysis
MH Pittler et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2000)
分享论文
